Premium
Pancreatic B‐cell functioning after intravenous glucagon administration in anorexia nervosa
Author(s) -
Kobayashi N.,
Tamai H.,
Takii M.,
Matsubayashi S.,
Nakagawa T.
Publication year - 1992
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1992.tb01433.x
Subject(s) - glucagon , medicine , anorexia nervosa , endocrinology , insulin , body weight , weight loss , obesity , eating disorders , psychiatry
Abnormal glucose tolerance is often found in patients with anorexia nervosa (AN). We attempted to evaluate pancreatic B‐cell functioning after intravenous glucagon administration. Fourteen patients with the restricting type of AN (percentage of ideal body weight 71.5 ± 1.6%, mean ± SE) and 6 patients with the bulimic type of AN (77.0 ± 3.0%) were studied. After an overnight fast, glucagon (0.02 mg/kg) was injected i.v. into all subjects and 6 normal controls. Blood samples were obtained at 0, 5, 30, 60, 90 and 120 min to measure blood glucose (BS), serum insulin (IRI) and C‐peptide (CPR). The same tests were repeated in 8 patients with restricting AN after therapy and restoration of body weight (85.9 ± 1.0% of ideal body weight). BS responses did not differ among the groups. Peak serum levels (5 min) of both IRI and CPR in restricting AN patients were significantly lower than those in bulimic AN patients and in normal controls. BS, IRI and CPR concentrations did not change significantly following restoration of body weight. Pancreatic B‐cell dysfunction after glucagon administration was observed in restricting AN patients and the abnormality persisted after short‐term weight restoration.